Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MEDX vs SCHLX overlap: 51% of top holdings shared

Bottom line

How much do MEDX and SCHLX overlap?

51% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 62.0% of MEDX's assets and 43.5% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

MEDXSCHLX
Weight overlap (top 25)51%
Shared holdings10
Weight in shared holdings62.0%43.5%
Total positions3365
Expense ratio0.85%1.06%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings MEDX and SCHLX have in common

Holding% of MEDX% of SCHLXOverlap
Eli Lilly & Co LLY18.46%13.85%13.85%
AbbVie Inc ABBV8.85%4.90%4.90%
Novartis AG NVS6.89%2.90%2.90%
Johnson & Johnson JNJ5.59%6.19%5.59%
AstraZeneca PLC AZN4.98%3.80%3.80%
Bristol-Myers Squibb Co BMY4.42%1.50%1.50%
Merck & Co Inc MRK3.96%4.85%3.96%
Amgen Inc AMGN3.91%2.88%2.88%
Pfizer Inc PFE2.86%1.17%1.17%
Regeneron Pharmaceuticals Inc REGN2.06%1.43%1.43%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MEDX

  1. US Bank Mmda - Usbgfs 7 — 9.19%
  2. Alkermes PLC — 5.53%
  3. Ionis Pharmaceuticals Inc — 4.53%
  4. Alnylam Pharmaceuticals Inc — 3.42%
  5. Biogen Inc — 3.09%
  6. Gsk Plc — 2.71%
  7. CRISPR Therapeutics AG — 2.64%
  8. Beam Therapeutics Inc — 1.51%
  9. Galectin Therapeutics Inc — 1.14%
  10. Intellia Therapeutics Inc — 1.12%
  11. Sandoz Group AG — 0.80%
  12. Replimune Group Inc — 0.73%
  13. Vanda Pharmaceuticals Inc — 0.73%
  14. Haleon PLC — 0.60%
  15. Lantern Pharma Inc — 0.55%

Only in SCHLX

  1. UnitedHealth Group Inc — 5.73%
  2. Thermo Fisher Scientific Inc — 3.46%
  3. Gilead Sciences Inc — 2.78%
  4. Intuitive Surgical Inc — 2.69%
  5. Stryker Corp — 2.61%
  6. Vertex Pharmaceuticals Inc — 2.45%
  7. Abbott Laboratories — 2.39%
  8. Danaher Corp — 2.13%
  9. Boston Scientific Corp — 2.10%
  10. McKesson Corp — 2.05%
  11. Novo Nordisk A/S — 1.73%
  12. Medtronic PLC — 1.54%
  13. Cardinal Health Inc — 1.34%
  14. Cencora Inc — 1.26%
  15. Roche Holding AG — 1.24%

Asset mix

Asset typeMEDXSCHLX
Stocks92.6%99.6%
Cash & short-term funds9.2%0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryMEDXSCHLX
US77.4%85.7%
CH10.3%5.2%
GB8.6%3.8%
IE5.5%1.5%
DK—1.7%
FR—1.0%
NL—1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do MEDX and SCHLX overlap?
About 51% by weight. 10 securities appear in both funds' top 25 holdings; they make up 62.0% of MEDX's assets and 43.5% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do MEDX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, AstraZeneca PLC.
Should I own both MEDX and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, MEDX or SCHLX?
SCHLX is broader, with 65 positions versus 33 for MEDX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.